Early research (Phase 1)UnknownNCT02888418
What this trial is testing
Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
Who this might be right for
Cervical Cancer
Beijing Chaoyang District Centre for Disease Control and Prevention 135